Dr Reddys Laboratories (RDY) Operating Income (2016 - 2025)
Historic Operating Income for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $159.9 million.
- Dr Reddys Laboratories' Operating Income fell 2788.94% to $159.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $794.9 million, marking a year-over-year decrease of 291.13%. This contributed to the annual value of $842.0 million for FY2025, which is 356.7% up from last year.
- Per Dr Reddys Laboratories' latest filing, its Operating Income stood at $159.9 million for Q4 2025, which was down 2788.94% from $203.8 million recorded in Q1 2025.
- In the past 5 years, Dr Reddys Laboratories' Operating Income ranged from a high of $221.7 million in Q4 2024 and a low of $19.0 million during Q4 2021
- In the last 5 years, Dr Reddys Laboratories' Operating Income had a median value of $195.0 million in 2022 and averaged $171.6 million.
- Its Operating Income has fluctuated over the past 5 years, first plummeted by 8173.08% in 2021, then soared by 69473.68% in 2022.
- Dr Reddys Laboratories' Operating Income (Quarter) stood at $19.0 million in 2021, then surged by 694.74% to $151.0 million in 2022, then skyrocketed by 37.33% to $207.4 million in 2023, then rose by 6.91% to $221.7 million in 2024, then dropped by 27.89% to $159.9 million in 2025.
- Its Operating Income stands at $159.9 million for Q4 2025, versus $203.8 million for Q1 2025 and $221.7 million for Q4 2024.